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Abstract
Background: The metabolic function of PEPCK-C is not fully understood; deletion of the gene
for the enzyme in mice provides an opportunity to fully assess its function.
Methods: The gene for the cytosolic form of phosphoenolpyruvate carboxykinase (GTP) (EC
4.1.1.32) (PEPCK-C) was deleted in mice by homologous recombination (PEPCK-C-/- mice) and the
metabolic consequences assessed.
Results: PEPCK-C-/- mice became severely hypoglycemic by day two after birth and then died with
profound hypoglycemia (12 mg/dl). The mice had milk in their stomachs at day two after birth and
the administration of glucose raised the concentration of blood glucose in the mice but did not
result in an increased survival. PEPCK-C-/- mice have two to three times the hepatic triglyceride
content as control littermates on the second day after birth. These mice also had an elevation of
lactate (2.5 times), β-hydroxybutyrate (3 times) and triglyceride (50%) in their blood, as compared
to control animals. On day two after birth, alanine, glycine, glutamine, glutamate, aspartate and
asparagine were elevated in the blood of the PEPCK-C-/- mice and the blood urea nitrogen
concentration was increased by 2-fold. The rate of oxidation of [2-14C]-acetate, and [5-14C]-
glutamate to 14CO2 by liver slices from PEPCK-C-/- mice at two days of age was greatly reduced, as
was the rate of fatty acid synthesis from acetate and glucose. As predicted by the lack of PEPCK-
C, the concentration of malate in the livers of the PEPCK-C-/- mice was 10 times that of controls.
Conclusion:  We conclude that PEPCK-C is required not only for gluconeogenesis and
glyceroneogenesis but also for cataplerosis (i.e. the removal of citric acid cycle anions) and that the
failure of this process in the livers of PEPCK-C-/- mice results in a marked reduction in citric acid
cycle flux and the shunting of hepatic lipid into triglyceride, resulting in a fatty liver.
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Background
The factors that regulate the transcription of the gene for
the cytosolic form of phosphoenolpyruvate carboxykinase
(GTP) (EC 4.1.1.32) (PEPCK-C) have been studied in
great detail over the years [1]. However, its metabolic role
in the various tissues in which the gene is expressed has
received far less attention. Discussion of the function of
PEPCK-C in mammals has largely been confined to its
role in gluconeogenesis, with only a brief mention of
alternative possibilities. PEPCK-C has become an impor-
tant marker for hepatic gluconeogenesis; studies of the
mechanisms involved in diabetes and related diseases,
often include an analysis of the alterations in the mRNA
for PEPCK-C. What is seldom mentioned, however, is the
fact that PEPCK-C activity is present in a number of tissues
that do not make glucose, including white and brown adi-
pose tissue, mammary gland during lactation, small intes-
tine, brain, lung, muscle and a number of others (see [2]
for a review of this subject). Besides its role in gluconeogen-
esis, PEPCK-C is involved in glyceroneogenesis in adipose
tissue [3] and liver [4,5]. This pathway is an abbreviated
version of gluconeogenesis and results in the synthesis of
glyceride-glycerol from precursors other than glucose or
glycerol [6,7]. PEPCK-C can also catalyze the formation of
oxalacetate, a citric acid cycle intermediate; it has been
suggested that the enzyme "refills" the cycle during peri-
ods of biosynthesis (a process known as anaplerosis). How-
ever, the major biosynthetic tissues such as the liver and
adipose tissue have considerable activity of pyruvate car-
boxylase, which itself generates oxalacetate. PEPCK-C is
also the major cataplerotic enzyme, (cataplerotic enzymes
remove citric acid cycle anions that are formed by the
entry of the carbon skeletons of amino acids into the
cycle). Both gluconeogenesis and glyceroneogenesis are
cataplerotic processes, which use intermediates of the cit-
ric acid cycle for their specific biosynthetic process. As we
will show in this paper, cataplerosis is a critical metabolic
function. Finally, Hahn and Nowak [8] proposed that in
brown adipose tissue a cycle operates between the mito-
chondria and the cytosol in which PEPCK-C converts GTP
to GDP, to insure a continued citric acid cycle flux (GDP
is a substrate for succinyl CoA synthase).
Ablating the gene for PEPCK-C in mice provides an oppor-
tunity to better assess the metabolic role of the enzyme in
mammalian tissues. The gene for PEPCK-C has been
deleted specifically in the livers of mice by She et al [9],
who noted that the mice had a greatly reduced rate of
hepatic gluconeogenesis from a variety of precursors.
However, the animals did not develop hypoglycemia,
even after as much as 48 hrs of fasting and could be
induced to develop diabetes [10]. The absence of PEPCK-
C in the liver also resulted in a decrease in the level of gly-
cogen in both the liver and muscle; there was also dimin-
ished whole-body glucose turnover. Mice in which the
gene for PEPCK-C has been totally deleted in all tissues
die in the first two days after birth with profound hypogly-
cemia. These findings indicate that the kidney (the second
gluconeogenic organ) can make sufficient glucose to pro-
vide for the needs of the animal during fasting and that it
responds to the hormonal alterations characteristic of dia-
betes by increasing renal glucose output.
A surprising finding from the studies of She et al [9] was
the observation that the ablation of the gene for PEPCK-C
caused the mice to develop a fatty liver. As we will report
here, the fatty liver appears as early as the end of the first
day after birth and is accompanied by a 5-fold elevation in
the concentration of triglyceride in the blood. While not
expected by conventional metabolic logic, the accumula-
tion of triglyceride in the liver could be the result of a fail-
ure of the development of glyceroneogenesis in adipose
tissue or to a loss of gluconeogenesis (the major cata-
plerotic pathway in the liver) in the absence of PEPCK-C.
In this paper we assess the impact of a loss of PEPCK-C in
the perinatal period and evaluate the various functions
suggested for this enzyme in energy metabolism.
Methods
Materials
Restriction enzymes, Taq DNA polymerase and proteinase
K, NAD, NADH, lactate dehydrogenase, and malate dehy-
drogenase were purchased from Roche Applied Science
(Indianapolis, IN). QuickPrep total RNA kit, [5-14C]-
sodium glutamate, [U-14C]-glucose, and [2-14C]-sodium
acetate was purchased from Amersham Biosciences Corp.
(Piscataway, NJ). Triglyceride (GPO) Liquid Reagent Set
was purchased from Pointe Scientific, Inc. (Lincoln Park,
MI). The NEFA kit was from Wako Chemicals USA, Inc.
(Richmond, VA). The embryonic stem cells used in this
study were a generous gift from Janet Rossant, University
of Toronto.
Generation and maintenance of PEPCK-C-/- mice
The gene for PEPCK-C was deleted in the mice as
described in figure 1. A targeting vector was constructed in
which the region of the PEPCK-C gene extending from a
Pst I site at ~-300 bp in the PEPCK-C gene promoter to an
Xho I site in exon three of the structural gene, was substi-
tuted with the PGK_βgal-neoR gene (figure 1A). The neo-
mycin resistance gene (neo) and the diphtheria toxin A
chain (DTA) were used as positive and negative selection
markers, respectively. The targeting vector was linearized
by Not I digestion and electroporated (25 µg of DNA) into
E14 embryonic stem cells. Targeted clones that underwent
homologous recombination were identified, using South-
ern blot hybridization of digested genomic DNA from ES
cells. The probe used was a PEPCK-C cDNA sequence
composed of exons one to six of the mouse PEPCK-C gene
(figure 1A). Two out of eight hundred of the G418 resist-Nutrition & Metabolism 2005, 2:33 http://www.nutritionandmetabolism.com/content/2/1/33
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ant clones, that had been screened, showed correct
homologous recombination. These clones were subse-
quently injected into C57BL/6 blastocytes to produce chi-
meric mice, which were then crossed with C57BL/6 mice
to establish germ-line founders. The resulting offspring
were genotyped by using Southern blotting or PCR.
Generation of PEPCK-C-/- mice Figure 1
Generation of PEPCK-C-/- mice. Panel A. Diagram of the targeting vector, which is aligned with endogenous sequence of 
PEPCK-C gene. The sequence between Pst I and Xho I, which covers part of the gene promoter and the exons 1 and 2 in 
endogenous gene, was replaced with Neo resistance gene (PGK_βgal-neoR) in the targeting vector. H, Hind III; P, Pst I; X, Xho 
I. PGK_βgal-neoR, the phosphoglycerate kinase gene promoter drives a fusion gene of βgal and neoR. DTA, the diphtheria 
toxin A chain. Panel B. Genotyping of the PEPCK-C-/- mice by Southern blotting. Genomic DNA was digested with Hind III and 
hybridized with a PEPCK-C cDNA probe composed of exons 1~6 of the rat PEPCK-C gene (black bars). For the wild type 
allele of PEPCK-C, 1.3-kb and 2.75-kb fragments were detected; only one fragment (2.5 kb) was excepted for the targeted 
allele.Nutrition & Metabolism 2005, 2:33 http://www.nutritionandmetabolism.com/content/2/1/33
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Metabolic studies
PEPCK-C-/- mice and control littermates at one to three
days of age were killed by decapitation. Their livers and
blood were collected. Livers slices (5 to 10 mg) were pre-
pared and incubated in a 10-ml Erlenmeyer flask, contain-
ing 1 ml of reaction buffer, which was composed of Krebs
Ringer bicarbonate buffer at pH 7.4, 1 % defatted bovine
serum albumin, and one of following substrates: 1 µCi [U-
14C] glucose (5 mM), 1 µCi [2-14C] sodium acetate (2
mM), or 1 µCi [U-14C] sodium glutamate (1 mM). The
flask had a thin rubber stopper that served both as a cap
to close the flask and to hold a plastic bucket. The incuba-
tion was carried out at 37°C for 2 h in an atmosphere of
O2/CO2 (95%/5%), in a shaking water bath. At the end of
the incubation period, 200 µl of hyamine hydroxide was
injected through the rubber stopper into the hanging
bucket and 0.5 ml of 10% perchloric acid was injected
into the incubation medium, to insure the complete liber-
ation of CO2. After shaking for an addition 30 min, the tis-
sue was removed, rinsed in saline and transferred to 2 ml
of chloroform-methanol (2:1 v/v) for the extraction of
total lipids. The lipid was extracted and its radioactivity
determined. The hanging buckets containing the hyamine
hydroxide were dissolved in liquid scintillation fluid and
the radioactivity measured using a liquid scintillation
spectrometer.
Body composition
Mice were killed at two days of age and carcass analysis
performed as described by Leischner et al.
Histology of the Liver
Segments of livers from 2-day-old mice were fixed in 10%
formalin (Sigma, St. Louis, MO) at 4°C. The tissues were
embedded in paraffin and stained with hematoxylin and
eosin by the Pathology Core Facility (Case Western
Reserve University, Cleveland, OH). The photographs
were taken at 400× magnification.
DNA Analysis
DNA was isolated from the tails of the mice by lysis over-
night at 55°C in a buffer containing 50 mM KCl, 10 mM
Tris-HCl, pH 8.3, 2.5 mM MgCl2, 0.1% gelatin, 0.45%
Nonidet P-40, 0.45% Tween20, and 24 mg/ml of protein-
ase K. The DNA was digested with Hind III, and the result-
ing fragments were separated by electrophoresis on 1%
agarose gel, transferred to Gene Screen Plus®, and hybrid-
ized to a cDNA probe for PEPCK-C.
RNA analysis
Total RNA was extracted from the livers of one and two-
day old mice using a QuickPrep total RNA kit (Amersham
Pharmacia Biotech) by a modified acid-phenol/guanidine
thiocynate procedure [11] and Northern blotting was per-
formed as described in detail previously [12]. Briefly, 20
µg of total RNA was separated by electrophoresis on an
agarose gel, transferred to a Gene Screen Plus membrane
and hybridized with a 1.0kb Sma I fragment of the 3'end
of the PEPCK-C cDNA. The DNA probe was labeled by
using [α-32P]-dCTP.
Biochemical analysis
The following metabolites were measured in the blood of
mice killed up to two days after birth. Blood glucose was
determined using an Encore® Glucometer. The concentra-
tions of triglyceride, β-hydroxybutyrate, and urea nitrogen
in the blood were determined by Veterinary Diagnostic
Services in Marshfield Laboratories (Marshfield, WI),
using standard clinical procedures. The concentrations of
amino acids in plasma were measured with a high-pres-
sure liquid spectrophotometer equipped with a fluores-
cent detector, using a o-phthaldehyde derivative and pre-
column derivatization [13]. Livers of mice were used to
determine the content of glycogen [14] or were freeze-
clamped and metabolites extracted as described previ-
ously [15]. Spectrophotometric methods were used to
determine the concentrations of malate [16], lactate [17],
pyruvate [18] and ammonia [19] in the liver extracts or in
the blood. The concentration of hepatic triglyceride was
determined using the triglyceride reagent set from Pointe
Scientific, Inc. (Lincoln Park MI). Briefly, segments of liver
were saponified in ethanol-KOH, the sample diluted 1:5
and one ml of triglyceride reagent added to 10 µl of
diluted sample and incubated at 37°C for 5 min. The reac-
tion product was analyzed using spectrophotometer
(A500) and the concentration determined by linear regres-
sion using standards treated with one ml of triglyceride
reagent. The activity of PEPCK-C in the liver cytosol of
two-day-old PEPCK-C-/- mice and control littermates was
determined as described by Ballard and Hanson [20] and
the activity expressed as units/g tissue, where one unit
equals one µmole of substrate converted to product per
min.
Statistical analysis
All data are reported as means ± the SE. The statistical
analysis was performed using SigmaPlot from Systat Soft-
ware, Inc. (Point Richmond, CA).
Results
A line of mice was created (PEPCK-C-/- mice) in which the
gene for PEPCK-C was deleted by inserting the neo resist-
ance gene, driven by the phosphoglycerate kinase gene
promoter, into the PEPCK-C gene, thereby deleting a
region of the gene from the Pst I site at -569 of the gene
promoter to the XhoI site within the third exon (figure 1).
The PEPCK-C-/- mice had no detectable mRNA for PEPCK-
C in the liver and kidney (the only tissues tested) (figure
2A) and no activity for the enzyme was noted in their liv-
ers (figure 2B). PEPCK-C-/- mice were present in litters atNutrition & Metabolism 2005, 2:33 http://www.nutritionandmetabolism.com/content/2/1/33
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the expected Mendalian ratio at birth, however, all of the
PEPCK-C-/- mice died within two to three days after birth.
The animals had no distinguishing phenotype at birth,
suckled normally and had milk in their stomachs (figure
2C). However, by one day after birth PEPCK-C-/- the mice
failed to gain weight (figure 2D) and had about half the
total body fat content of control littermates (Table 1).
Mice heterozygous for the PEPCK-C gene deletion (PEPCK-
C+/- mice) had only half the activity of the enzyme in their
livers (figure 2B) and lived normally, with no observable
metabolic abnormalities.
The effect of a deletion of the gene for PEPCK-C on glu-
cose homeostasis is evident from the changes in the con-
centration of glucose in the blood of PEPCK-C-/- mice, as
compared to control littermates. PEPCK-C activity first
appears in the liver at birth [20]. Thus, a deletion of the
gene for PEPCK-C should not have a significant effect on
glucose homeostasis before birth, since the glucose
needed for fetal development is provided by the mother.
One day after birth the levels of glucose in the blood of
PEPCK-C-/- mice was only 60% of that in controls, and by
day three the concentration of glucose in the blood of
these mice was 12.3 mg/dl (figure 3A). It is likely that a
failure of gluconeogenesis, caused by the ablation of
PEPCK-C [10] contributed to the low level of glucose in
the blood. The concentration of hepatic glycogen was
determined at fetal day 19 (one day before birth) and at
day two after birth in both PEPCK-C-/- mice and controls
(figure 3B). There was 10% less glycogen in the livers of
PEPCK-C-/- mice delivered one day before birth, as com-
pared to control animals. By two days after birth the con-
centration of hepatic glycogen was markedly decreased in
both PEPCK-C-/- mice and controls, but the overall level of
glycogen mobilization was much greater in the PEPCK-C-
/- mice (figure 3B). This is likely due to the need of he ani-
mal to rely the mobilized hepatic glycogen as a source of
glucose for fuel metabolism. Interestingly, the administra-
tion of glucose by intraperitoneal injection did not rescue
the mice from death at day two after birth (data not
shown), suggesting that factors other than a disruption of
glucose homeostasis were responsible for the death of the
mice (i.e. the great accumulation of hepatic triglyceride or
a failure of cataplerosis).
Despite having less body fat, PEPCK-C-/-  mice had a
marked hepatic lipid accumulation, which was visible
when the liver was removed from the animal for biochem-
istry analysis. Histological analysis of the livers of animals
at two days of age indicated extensive lipid infiltration of
the liver (figure 4). This accumulation of lipid progressed
until the mice died between two and three days after birth.
The metabolic profile of the PEPCK-C-/- mice at day two
after birth is shown in Table 1. The concentration of trig-
lyceride in the livers of these mice was twice that of con-
trols; this was accompanied by a similar, almost 2-fold
difference in the level of triglyceride in the blood of the
PEPCK-C-/- mice. The concentration of β-hydroxybutyrate
in the blood of PEPCK-C-/- mice was three times that of
control mice. In addition, the concentration of ammonia
in the blood of the PEPCK-C-/- mice was elevated 3-fold
over that noted in the blood of control mice, while blood
Table 1: Metabolic alterations in PEPCK-C-/- mice at two days of age. 
Body composition PEPCK-C+/+ (n) PEPCK-C-/- (n)
% Water 80.3 ± 0.30 3 79.26 ± 0.22 3
% Fat 3.48 ± 0.36 3 1.85 ± 0.57 3
% Lean Mass 16.42 ± 0.63 3 18.88 ± 0.78 3
Metabolites in liver
Triglyceride (µmoles/g) 4.17 ± 1.00 5 9.58 ± 1.75 5
Lactate (µmoles/g) 0.19 ± 0.02 3 0.37 ± 0.09 3
Malate (µmoles/g) 0.24 ± 0.05 3 2.84 ± 1.58 3
Metabolites in plasma
Triglyceride (mg/dl) 23.7 ± 6.3 3 36.3 ± 21.5 2
Ammonia (µmoles/ml) 0.14 ± 0.02 5 0.45 ± 0.28 4
BUN (mg/dl) 29.0 ± 7.0 2 65.5 ± 28.5 2
Lactate (µmoles/ml) 0.28 ± 0.13 3 0.72 ± 0.47 3
β-Hydoxybutyrate (µmoles/ml) 5.83 ± 0.21 3 17.95 ± 0.70 3
The values are expressed as the mean ± S.E. for the number of animals shown in parenthesisNutrition & Metabolism 2005, 2:33 http://www.nutritionandmetabolism.com/content/2/1/33
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urea nitrogen (BUN) was increased by 2-fold (Table 1),
suggesting an increased generation of amino nitrogen
from the breakdown of amino acids.
Since the deletion of the gene for PEPCK-C should alter
the levels of intermediates in related metabolic pathways,
we determined the level of malate and lactate in the liver
by freeze-clamping the livers of PEPCK-C-/- mice and con-
trols at two days after birth. Intermediates were extracted
from the frozen livers and their concentrations measured
(Table 1). The concentration of malate was increased by
10-fold in the livers of PEPCK-C-/- mice and the lactate
concentration was elevated 2.5-fold. We did not distin-
guish between the malate in the cytosol and the mito-
chondria, but it is likely that there is an increase in the
concentration of this citric acid cycle intermediate in both
compartments of the hepatocyte. This finding of an ele-
vated concentration of malate in the liver suggests that in
absence of PEPCK-C the rate of oxalacetate conversion to
PEP is limited and this intermediate is converted instead
to malate, which accumulates. A similar increase in the
concentration of malate in the livers of PEPCK-C-/- mice
was reported by She et al. [9].
It is not intuitive that the ablation of PEPCK-C, which is
normally classified as a gluconeogenic enzyme, would
result in profound fatty livers in the mice. However,
PEPCK-C is a major cataplerotic enzyme, so that its
absence in the liver would be predicted to alter the rate of
citric acid cycle flux, since a major route for the disposal of
carbon skeletons from the break down of amino acids
would be blocked. This is demonstrated in experiments in
which the rate of oxidation of acetate, glucose and gluta-
mate to CO2 and their conversion to total lipid by liver
slices from PEPCK-C-/- mice was compared with control
animals. The generation of 14CO2 from [2-14C]-acetate
was 30% of the rate of oxidation of this compound by
liver slices from control mice and the rate of hepatic lipid
synthesis by PEPCK-C-/- mice was negligible (Table 2). The
same pattern was noted for the metabolism of [U-14C]-
glucose. We also determined the rate of oxidation of [5-
14C]-glutamate, which enters the citric acid cycle as α-
ketoglutarate and must leave as malate or some other
four-carbon anion to insure continuing carbon flux
through the cycle. Gluconeogenesis is the most important
route of disposal of the carbon skeletons that enter the cit-
ric acid cycle; in the absence of PEPCK-C the rate of oxida-
tion of [5-14C]-glutamate to 14CO2  was markedly
diminished (Table 2).
The synthesis of non-essential amino acids from citric acid
cycle intermediates, such as oxalacetate (from aspartate
and asparagine) and α-ketoglutarate (from glutamate and
glutamine) is potentially capable of relieving the accumu-
lation of intermediates in the cycle that occurs in the livers
Characterization of the PEPCK-C-/- mice Figure 2
Characterization of the PEPCK-C-/- mice. Panel A. A 
representative Northern blot for mRNA isolated from the 
liver and kidney of two-day-old mice. Panel B. PEPCK-C 
activity was determined in the livers of two-day-old mice. 
The results are expressed as the mean ± S.E. for three ani-
mals in each group. Panel C. Photograph of two-day-old 
PEPCK-C-/- mice. Panel D. Growth retardation of PEPCK-C-/- 
mice. Body weights of neonates were measure at 6, 30, and 
37 h after birth. Three wild type mice and three PEPCK-C-/- 
mice were used.Nutrition & Metabolism 2005, 2:33 http://www.nutritionandmetabolism.com/content/2/1/33
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of PEPCK-C-/- mice [21]. We have measured the level of
amino acids in the blood of PEPCK-C-/- mice and controls
(figure 5). At two days after birth, there was a marked
increase in a number of the non-essential amino acids in
the blood of PEPCK-C-/- mice. The levels of alanine, aspar-
tate, asparagine, glutamate, glutamine and glycine in the
blood of the PEPCK-C-/-  mice were two to eight-fold
higher than noted in control animals. This suggests that
the carbon skeletons of these amino acids, which would
normally enter the citric acid cycle, are prevented from
being readily metabolized and the amino acids accumu-
late in the blood. It is also likely that some fraction of the
non-essential amino acids were synthesized de novo from
citric acid cycle intermediates, which accumulate in the
liver due to the absence of PEPCK-C. This suggestion is
supported by the increased concentration of ammonia in
the blood of the PEPCK-C-/- mice (see Table 1), which
favors the formation of non-essential amino acids in the
liver, especially glutamine, which was elevated five times
over that noted in the blood of control animals. The con-
centration in the blood of a number of the essential
amino acids, such as lysine, methionine, phenylalanine
and tryptophan was not altered by ablation of PEPCK-C,
while the levels of leucine, isolucine and valine were
increased. The elevation in the level of ornithine, together
with the elevated levels of both ammonia and urea in the
blood of the PEPCK-C-/- mice suggests elevated urea cycle
flux to dispose of amino nitrogen from the breakdown of
amino acids.
Discussion
It is clear from this and other studies [9,10] that PEPCK-C
is critical for life; its absence in the mouse results in death
within the first two to three days after birth. We are aware
of only one reported example of PEPCK-C deficiency in
humans. In 1976, Vidnes and Sovik [22] reported the
absence of PEPCK-C in the liver of an infant, which had
persistent hypoglycemia and an early death, despite the
presence of PEPCK-M. The rarity of PEPCK-C deficiency in
humans further supports the physiological significance of
this enzyme. The developmental profile of hepatic
PEPCK-C is of interest in this regard. PEPCK-C is absent in
the liver of all mammals during fetal development and
appears dramatically at birth [20]. In contrast, the enzyme
is present in the kidney [23] and may appear in other tis-
sues before birth, but the exact pattern of development in
tissues other than the kidney and liver has not been deter-
mined. As an example, the time course of development of
PEPCK-C in white adipose tissue is currently unknown,
despite the important role that PEPCK-C plays in this tis-
sue [3,7]. Considerable PEPCK-M activity is present in
mammalian liver before birth [24] but it is the appearance
of PEPCK-C at birth and the marked alteration in the
hepatic redox state, which occurs during this period [25],
that are generally considered to be the important events in
Alterations in glucose homeostaisis in PEPCK-C-/- and con- trol mice during the perinatal period Figure 3
Alterations in glucose homeostaisis in PEPCK-C-/- 
and control mice during the perinatal period. Panel A 
Hypoglycemia in PEPCK-C-/- mice. The concentration of 
blood glucose was measured in mice at one, two and three 
days after birth. The results are expressed as the mean ± S.E. 
for from three to six animals. Panel B. Increased mobilization 
of hepatic glycogen. The hepatic glycogen level was analyzed 
at the age of fetal day 19 (day -1) and neonatal day (day +2). 
The results are expressed as the mean ± S.E. for three ani-
mals in each group.Nutrition & Metabolism 2005, 2:33 http://www.nutritionandmetabolism.com/content/2/1/33
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the initiation of hepatic gluconeogenesis. Since the role of
PEPCK-C in gluconeogenesis is well established in all spe-
cies [26], it is reasonable to assume that one of the causes
of the death of the PEPCK-C-/- mice is the profound
hypoglycemia which occurs at two to three days after
birth. However, providing glucose to the mice by intra-
peritoneal injection did not rescue the animals.
Mice with a liver-specific deletion of the gene for PEPCK-C
survive the perinatal period, maintain normal glucose
homeostasis during fasting and can be made diabetic [10].
Whole body glucose turnover in these mice is only slightly
decreased, when compared to control animals. This sug-
gests that the kidney can assume the function of the liver
and make enough glucose for the needs of the animal. In
addition, the liver can synthesize glucose from glycerol, a
process that by-passes the reactions in the pathway of glu-
coneogenesis that require PEPCK-C. Since only 5–10% of
the total PEPCK is mitochondrial in rodent species [27], it
is unlikely that PEPCK-M plays a significant role in
hepatic gluconeogenesis in mice lacking hepatic PEPCK-
C. Mice lacking hepatic PEPCK-C have lower levels of liver
glycogen two days after birth. As noted in Table 1, new-
born PEPCK-C-/- mice have considerably less glycogen
than control littermates, presumably due to the need to
mobilized glycogen to support the blood glucose levels in
the absence of hepatic gluconeogenesis. However, She et
al [9] reported that mice lacking PEPCK-C in the liver had
a greatly reduced rate of glycogen synthesis in both the
liver and the muscle.
The marked accumulation of fat in the livers of the
PEPCK-C-/- mice strongly suggests that there is another
critical metabolic role for the enzyme (other than gluco-
neogenesis) which, when missing, can markedly alter the
metabolic capacity of the animal. The concentration of
hepatic triglyceride in mice two days after birth is twice
that of control animals. The biochemical mechanisms
responsible for the accumulation of triglyceride in
PEPCK-C-/- mice are complex. In the present paper, we
present evidence that in the absence of PEPCK-C hepatic
cataplerosis is greatly reduced, resulting in a reduction of
Morphology of the livers of PEPCK-C-/- and control mice Figure 4
Morphology of the livers of PEPCK-C-/- and control mice. Livers of two-day-old pups were analyzed with H&E staining. 
The arrow indicates fat accumulation in the liver of PEPCK-C-/- mice.
Table 2: The conversion of glucose, acetate and glutamate to CO2 and lipid by liver slices from PEPCK-C-/- and control mice.
CO2 Total Lipid
Substrates PEPCK-C+/+ (n) PEPCK-C-/- (n) PEPCK-C+/+ (n) PEPCK-C-/- (n)
Glucose-U-14C 0.92 ± 0.26 (8) 0.30 ± 0.04 (5) 0.153 ± 0.009 (3) 0.063 ± 0.002 (2)
Acetate-2-14C 12.36 ± 0.88 (4) 2.72 ± 0.20 (5) 0.097 ± 0.018 (7) 0.002 ± 0.000 (2)
Glutamate-5-14C 5.15 ± 0.65 (2) 1.75 ± 0.65 (2) 1.778 ± 0.091 (4) 0.983 ± 0.098 (3)
The values are expressed as µmoles of substrate converted to product/hour/g liver and represent the mean ± SE of the mean for the number of 
determinations shown in parenthesis. Livers slices from two-day-old mice were incubated for 2 h in Krebs Ringer bicarbonate buffer, pH 7.4, 
containing substrates at the concentrations outlined in the Methods, and the rates of 14CO2 production and 14C incorporation into total lipid 
determined. The radioactivity was quantified using a liquid scintillation spectrometer.Nutrition & Metabolism 2005, 2:33 http://www.nutritionandmetabolism.com/content/2/1/33
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the ability of the liver to appropriately oxidize acetyl CoA
to CO2 in the citric acid cycle. This causes an increase in
the synthesis of ketone bodies and a build up of fatty acids
in the liver, with the subsequent synthesis of triglyceride.
Cataplerosis describes reactions involved in the disposal of
citric acid cycle intermediates generated by the entry of
compounds into the cycle during the breakdown of
amino acids and other metabolites (i.e. propionyl CoA),
or by the carboxylation of pyruvate to oxalacetate [28].
The biological necessity for cataplerosis resides in citric
acid cycle dynamics. The cycle oxidizes acetyl CoA to CO2
but cannot fully oxidize four or five carbon intermediates.
This requires a series of reactions that are capable of effi-
ciently removing citric acid cycle anions before they accu-
mulate in the mitochondria. It is now recognized that
PEPCK-C functions in cataplerosis in many tissue, not just
in the more intensively studied tissues, such as the liver
and kidney. For example, the net generation of alanine
from glutamine, as occurs in the small intestine, involves
PEPCK-C and cataplerosis. Glutamine carbon enters the
citric acid cycle as α-ketoglutarate, is converted in the cycle
to malate, which leaves the mitochondria, is oxidized to
oxalacetate and then decarboxylated to PEP by PEPCK-C.
Pyruvate kinase then converts the PEP to pyruvate, the
pyruvate is transaminated by alanine aminotransferase to
alanine, which is then released into the blood and trans-
ported to the liver. It has been estimated that as much as
40% of the alanine used for gluconeogenesis by the
human liver during starvation is derived from the
glutamine in the small intestine [29]. Alternatively, the
pyruvate can be converted to acetyl CoA in the mitochon-
dria for the generation of energy via the citric acid cycle. A
similar role for PEPCK-C has been proposed for the con-
version of other amino acids to alanine in the muscle [30].
Deleting the gene for PEPCK-C in tissues of the mouse,
where it is normally present, will have the effect of altering
cataplerosis and profoundly interfering with energy
metabolism.
The results of the present study suggest that in the absence
of PEPCK-C in the liver the rate of removal of intermedi-
ates from the citric acid cycle is greatly reduced. This is
illustrated in figure 6. The high concentration of malate
(10 times that noted in controls) in the livers of PEPCK-C-
/- mice is most likely due to the lack of removal of oxalac-
etate in the absence of PEPCK-C. As malate accumulates,
the rate of citric acid cycle flux is markedly reduced, result-
ing in a decrease in both the oxidation of acetyl CoA to
CO2 and its conversion to fatty acid in the livers of PEPCK-
C-/- mice, as well as a reduction in the rate of oxidation of
glucose and glutamate to CO2 (see Table 2). The acetyl
CoA not utilized in the citric acid cycle is converted to
ketone bodies, which increase in the blood of the PEPCK-
C-/- mice (Table 1). The decreased oxidation of acetyl CoA
in the citric acid cycle results in the shunting of fatty acids
into the synthesis of triglyceride, with the subsequent
accumulation of fat in the liver. As would be predicted,
the absence of PEPCK-C results in an increase in the level
of a number of non-essential amino acids, including
aspartate, asparagine, glutamate, glycine, alanine and
glutamine that are synthesized from citric acid cycle ani-
ons. When hepatic PEPCK-C is ablated, the synthesis and
release of these amino acids from the liver serves as a
major cataplerotic process. An alteration in citric acid
cycle flux would thus contribute to the observed accumu-
lation of these amino acids in the blood. Clearly, the fail-
ure of the liver to carry out cataplerosis has far reaching
effects on energy metabolism in the animal. It should be
noted, however, that genetic disorders in humans in
which the activity of pyruvate carboxylase is reduced
results in the development of a fatty liver, suggesting that
The concentration of amino acids in the blood of PEPCK-C-/-  mice and controls Figure 5
The concentration of amino acids in the blood of 
PEPCK-C-/- mice and controls. The levels of amino acids 
were determined in mice at two days after birth. The results 
are expressed as the mean ± S.E. of three controls and four 
PEPCK-C-/- mice.Nutrition & Metabolism 2005, 2:33 http://www.nutritionandmetabolism.com/content/2/1/33
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The role of PEPCK-C in cataplerosis in the liver Figure 6
The role of PEPCK-C in cataplerosis in the liver. The reactions of the citric acid cycle are presented, with the major 
end-products shown in gold boxes; the large red box represents the mitochondrial membrane. The concentrations of amino 
acids, β-hydroxybutyrate, glucose and triglyceride were determined from blood samples, while the levels of malate and pyru-
vate were determined from freeze-clamped liver. The ablation of PEPCK-C (shown by a red bar) results in a 10-fold increase in 
the concentration of malate in the liver (we did not distinguish between malate in the cytosol and the mitochondria) and a 
build-up of cycle intermediates [23]. This leads to a decrease in the rate of citric acid cycle flux and the resultant accumulation 
of acetyl CoA, which is subsequently converted to ketone bodies and released by the liver. The rate of fatty acid oxidation in 
the PEPCK-C-/- mice is also markedly decreased, resulting in an increase in triglyceride synthesis from these fatty acids that 
leads to the development of a fatty liver. There is also a marked increase in the concentration of amino acids in the blood that 
were generated from citric acid cycle intermediates. The increased rate of flux of intermediates leaving the citric acid cycle is 
denoted by heavy arrows.Nutrition & Metabolism 2005, 2:33 http://www.nutritionandmetabolism.com/content/2/1/33
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a failure of anaplerosis can also result in hepatic fat accu-
mulation.
Mice with a liver-specific ablation of PEPCK-C have been
used by Burgress et al [21] to determine the importance of
this enzyme in citric acid cycle flux in the intact animal.
They noted that after a 24 h fast virtually all of the newly
synthesized glucose was from glycerol and the formation
of glucose from citric acid cycle intermediates was negligi-
ble. Flux through the citric acid cycle was 10 to 40-fold
lower than noted in the livers of control mice, which cor-
related with an accumulation of citric acid cycle interme-
diates. They concluded that in the absence of PEPCK-C
there was a failure of cataplerosis, leading to a decreased
citric acid cycle flux, decreased fatty acid oxidation and an
accumulation of liver lipid. This finding is in accord with
that described in this paper using mice in which the gene
for PEPCK-C is deleted in all tissues and underscores the
key role of PEPCK-C in the normal functioning of the cit-
ric acid cycle in mammals.
In addition to altering cataplerosis, the deletion of the
gene for PEPCK-C will result in a decrease in glyceroneo-
genesis in tissues of the mouse. At birth the mouse ingests
milk that is relatively high in fat (13%) and low in carbo-
hydrate (3%) when compared with some other mamma-
lian species (i.e. human). This dietary fat, while a good
source of energy, is deposited in white adipose tissue dur-
ing the early perinatal period. The relatively low level of
carbohydrate in the diet suggests that glyceroneogenesis
in adipose tissue could play an important role in control-
ling the rate of triglyceride deposition in this tissue during
suckling. Studies in our laboratory, using in vivo tracer
methodology, have shown that glyceroneogenesis in adi-
pose tissue of the rat is the predominant source of glycer-
ide-glycerol, even when the animals were fed a diet high
in sucrose (Nye, Hanson and Kalhan, unpublished data).
If glyceroneogenesis is playing an important role in the
deposition of triglyceride in the adipose tissue of the new-
born mouse, the absence of PEPCK-C in the tissue could
explain the very high level of triglyceride accumulation
noted in the livers of the PEPCK-C-/- mice, since fatty acids
not re-esterifed to triglyceride in adipose tissue, could end
up being converted to triglyceride in the liver. In support
of this suggestion, the tissue-specific ablation of PEPCK-C
gene expression in adipose tissue of mice resulted in the
development of a fatty liver.
Conclusion
The studies presented here and the recent work on mice
with a liver-specific deletion in the gene for PEPCK-C
[9,10,21], emphasize the important role played by this
enzyme in a number of metabolic process other than glu-
coneogenesis. It is likely that PEPCK-C is critical for cata-
plerosis, especially in those tissues in which significant
levels of biosynthesis occur. The dynamic nature of the cit-
ric acid cycle and its role in both energy generation and
biosynthetic process requires the coordinated activity of
PEPCK-C to insure a balance between carbon input into
the cycle and carbon outflow. The fact that this critical
function of PEPCK-C has not been appreciated for so
long, underlines the importance of genetically modified
animal models as tools for better understanding the con-
trol of metabolism. As an example, the metabolic func-
tion of PEPCK-M has been virtually ignored over the years
despite the fact that it represents 50% of the activity of
PEPCK in humans. This neglect is ironic, since Utter and
Kurahashi discovered PEPCK-M in the livers of chickens
[31] and used it to delineate the pathway of gluconeogen-
esis. Our understanding of the biology of PEPCK will not
be complete until we directly determine the metabolic
role of PEPCK-M in mammalian species. In this regard,
the major limiting factor is the fact that the animal species
most easily genetically modified (the mouse) has only a
marginal activity of PEPCK-M in any tissue. It should be
possible, however, to introduce a transgene containing
the gene PEPCK-M into tissues of PEPCK-C-/- mice. This
would allow us to assess the metabolic function of
PEPCK-M in the absence of PEPCK-C; these studies are in
progress.
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